propranolol has been researched along with Death, Sudden, Cardiac in 26 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
Excerpt | Relevance | Reference |
---|---|---|
"This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 9.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
"In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 7.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
"This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 5.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
"A 35-year-old black woman with a history of bronchial asthma collapsed and died after ingestion of three 20-mg tablets of propranolol." | 3.72 | An unusual death in an asthmatic patient. ( Spitz, DJ, 2003) |
"In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 3.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
"Most studies of the timing of onset of sudden cardiac death have revealed a prominent midmorning peak, thought to be related to a surge in catecholamines associated with arising and assuming the upright posture, that is blunted or eliminated by beta blockers." | 2.39 | Circadian patterns and triggers of sudden cardiac death. ( Peters, RW, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (42.31) | 18.2507 |
2000's | 7 (26.92) | 29.6817 |
2010's | 8 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tofler, GH | 1 |
Spinaze, M | 1 |
Shaw, E | 1 |
Buckley, T | 1 |
Calvillo, L | 1 |
Spazzolini, C | 1 |
Vullo, E | 1 |
Insolia, R | 1 |
Crotti, L | 2 |
Schwartz, PJ | 6 |
Fabritz, L | 1 |
Franz, MR | 1 |
Carmeliet, E | 1 |
Kirchhof, P | 1 |
Abu-Zeitone, A | 1 |
Peterson, DR | 1 |
Polonsky, B | 1 |
McNitt, S | 1 |
Moss, AJ | 1 |
Wang, H | 1 |
Tang, W | 1 |
Ristagno, G | 1 |
Li, Y | 1 |
Sun, S | 1 |
Wang, T | 1 |
Weil, MH | 1 |
McMurray, JJ | 1 |
Gemma, LW | 1 |
Ward, GM | 1 |
Dettmer, MM | 1 |
Ball, JL | 1 |
Leo, PJ | 1 |
Doria, DN | 1 |
Kaufman, ES | 1 |
Lampert, R | 1 |
Ickovics, JR | 1 |
Viscoli, CJ | 1 |
Horwitz, RI | 1 |
Lee, FA | 1 |
Adamson, PB | 1 |
Vanoli, E | 2 |
Shibano, T | 1 |
Foreman, RD | 2 |
Spitz, DJ | 1 |
Kriebel, T | 1 |
Korte, T | 1 |
Kandolf, R | 1 |
Jux, C | 1 |
Windhagen-Mahnert, B | 1 |
Bökenkamp, R | 1 |
Bertram, H | 1 |
Paul, T | 1 |
Aouate, P | 1 |
Clerc, J | 1 |
Viard, P | 1 |
Seoud, J | 1 |
Wang, JF | 1 |
Meissner, A | 1 |
Malek, S | 1 |
Chen, Y | 1 |
Ke, Q | 1 |
Zhang, J | 1 |
Chu, V | 1 |
Hampton, TG | 1 |
Crumpacker, CS | 1 |
Abelmann, WH | 1 |
Amende, I | 1 |
Morgan, JP | 1 |
Aronow, WS | 3 |
Ahn, C | 3 |
Mercando, AD | 3 |
Epstein, S | 3 |
Kronzon, I | 1 |
Hull, SS | 1 |
Ferrari, A | 1 |
McCurdy, CM | 1 |
Rutherford, SE | 1 |
Coddington, CC | 1 |
Garson, A | 1 |
Dick, M | 1 |
Fournier, A | 1 |
Gillette, PC | 1 |
Hamilton, R | 1 |
Kugler, JD | 1 |
van Hare, GF | 1 |
Vetter, V | 1 |
Vick, GW | 1 |
De Ferrari, GM | 1 |
Salvati, P | 1 |
Grossoni, M | 1 |
Ukmar, G | 1 |
Vaga, L | 1 |
Patrono, C | 1 |
Peters, RW | 1 |
Nademanee, K | 1 |
Veerakul, G | 1 |
Nimmannit, S | 1 |
Chaowakul, V | 1 |
Bhuripanyo, K | 1 |
Likittanasombat, K | 1 |
Tunsanga, K | 1 |
Kuasirikul, S | 1 |
Malasit, P | 1 |
Tansupasawadikul, S | 1 |
Tatsanavivat, P | 1 |
Shivkumar, K | 1 |
Schultz, L | 1 |
Goldstein, S | 1 |
Gheorghiade, M | 1 |
Andreotti, F | 1 |
Kluft, C | 1 |
Davies, GJ | 1 |
Huisman, LG | 1 |
de Bart, AC | 1 |
Maseri, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population[NCT04232787] | 750 participants (Anticipated) | Observational [Patient Registry] | 2016-01-28 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for propranolol and Death, Sudden, Cardiac
Article | Year |
---|---|
Circadian patterns and triggers of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Circadian Rhythm; Coronary Disease; Death, Sudden, Cardiac; Defibrillat | 1996 |
6 trials available for propranolol and Death, Sudden, Cardiac
Article | Year |
---|---|
β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.
Topics: Adrenergic beta-Antagonists; Adult; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography | 2011 |
Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Autonomic Nervous System; Death, Sudden, Cardiac; Female; | 2003 |
Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Echocardiography; Ele | 1994 |
Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Electrocard | 1995 |
Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Female; Hea | 1994 |
Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography; Femal | 1998 |
19 other studies available for propranolol and Death, Sudden, Cardiac
Article | Year |
---|---|
Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Death, Sudden, Cardiac; Drug Therapy, | 2013 |
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Conduction System Disease; Death, Sudden, Cardiac; Dis | 2014 |
To the Editor--Propranolol, a β-adrenoreceptor blocker, prevents arrhythmias also by its sodium channel blocking effect.
Topics: Animals; Death, Sudden, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Propranolol | 2014 |
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
Topics: Animals; Death, Sudden, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Propranolol | 2014 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Death, Su | 2009 |
Heart failure: acute ischemic events in HF--should we include sudden death?
Topics: Adrenergic beta-1 Receptor Antagonists; Antihypertensive Agents; Benzopyrans; Death, Sudden, Cardiac | 2011 |
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Long QT Sy | 2011 |
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Death, Sudde | 2003 |
An unusual death in an asthmatic patient.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Death, Sudden, Cardiac; Female; Humans; Medication Error | 2003 |
[Arrhythmogenic right ventricular dysplasia/cardiomyopathy - diagnosis in childhood].
Topics: Adolescent; Adult; Age Factors; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; | 2003 |
Propranolol intoxication revealing a Brugada syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atropine; Bundle-Branch Block; Death, Sudden, Cardiac; Electroca | 2005 |
Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.
Topics: Acute Disease; Adrenergic Agonists; Adrenergic beta-Antagonists; Amnion; Animals; Arrhythmias, Cardi | 2005 |
Alpha 1-adrenergic blockade and sudden cardiac death.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac | 1994 |
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric | 1993 |
The long QT syndrome in children. An international study of 287 patients.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocard | 1993 |
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.
Topics: Animals; Autonomic Nervous System; Coronary Circulation; Death, Sudden, Cardiac; Depression, Chemica | 1993 |
Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Asia, Southeastern; Bundle-Branch Block; Death, Sudden, C | 1997 |
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1.
Topics: Adult; Circadian Rhythm; Death, Sudden, Cardiac; Delayed-Action Preparations; Female; Humans; Incide | 1991 |